Karin Tollefson: Ensuring the Right Care for Those with ALK+ Lung Cancer
Karin Tollefson, Chief Oncology Medical Officer Pfizer, shared a post on LinkedIn about recent paper by Nancee Pronsati et al., published in Lung Cancer.
“Collaboration and open dialogue between patients and their healthcare providers form the foundation for truly empowering patient care. A recent publication in the journal Lung Cancer, written in collaboration with people living with ALK+ advanced non-small cell Lung Cancer (NSCLC), medical experts, and ALK Positive, provides guidance that reinforces the critical role active, informed patients can have in their treatment journey.
This novel and practical therapy management guide draws on clinical data and real-world experiences to help patients and caregivers understand what to expect from treatment while encouraging proactive communication throughout every stage of care.
Through shared decision making, earlier detection, and heightened awareness, we can work together to ensure those affected by ALK+ advanced NSCLC, a typically aggressive form of lung cancer, receive the most appropriate care.”
ALK Positive shared this post on LinkedIn, adding:
“We’re proud to have collaborated on this important guide with leading medical experts, and—most importantly—people living with ALK+ lung cancer.
When patients are informed, proactive, and truly heard, we move closer to the care everyone deserves. Resources like this help make that possible.”
Title: Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
Authors: Nancee Pronsati, Geoffrey Liu, Todd M. Bauer, Enriqueta Felip, Yasushi Goto, Gerald Green, Mary Grizzard, Michael Hamel, Julien Mazieres, Tony Mok, Stephanie Snow, Benjamin J. Solomon, Jan Stratmann, and Ken Culver
Read The Full Article at Lung Cancer.
More Posts Featuring NSCLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023